These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 34569339)

  • 1. A scoping review of the pathophysiology of COVID-19.
    Marik PE; Iglesias J; Varon J; Kory P
    Int J Immunopathol Pharmacol; 2021; 35():20587384211048026. PubMed ID: 34569339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is the COVID-19 thrombotic catastrophe complement-connected?
    Conway EM; Pryzdial ELG
    J Thromb Haemost; 2020 Nov; 18(11):2812-2822. PubMed ID: 32762081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe COVID-19: A multifaceted viral vasculopathy syndrome.
    Magro CM; Mulvey J; Kubiak J; Mikhail S; Suster D; Crowson AN; Laurence J; Nuovo G
    Ann Diagn Pathol; 2021 Feb; 50():151645. PubMed ID: 33248385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coagulopathy, endothelial dysfunction, thrombotic microangiopathy and complement activation: potential role of complement system inhibition in COVID-19.
    Wang X; Sahu KK; Cerny J
    J Thromb Thrombolysis; 2021 Apr; 51(3):657-662. PubMed ID: 33063256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue-Specific Immunopathology in Fatal COVID-19.
    Dorward DA; Russell CD; Um IH; Elshani M; Armstrong SD; Penrice-Randal R; Millar T; Lerpiniere CEB; Tagliavini G; Hartley CS; Randle NP; Gachanja NN; Potey PMD; Dong X; Anderson AM; Campbell VL; Duguid AJ; Al Qsous W; BouHaidar R; Baillie JK; Dhaliwal K; Wallace WA; Bellamy COC; Prost S; Smith C; Hiscox JA; Harrison DJ; Lucas CD
    Am J Respir Crit Care Med; 2021 Jan; 203(2):192-201. PubMed ID: 33217246
    [No Abstract]   [Full Text] [Related]  

  • 6. Pathophysiology of SARS-CoV-2: the Mount Sinai COVID-19 autopsy experience.
    Bryce C; Grimes Z; Pujadas E; Ahuja S; Beasley MB; Albrecht R; Hernandez T; Stock A; Zhao Z; AlRasheed MR; Chen J; Li L; Wang D; Corben A; Haines GK; Westra WH; Umphlett M; Gordon RE; Reidy J; Petersen B; Salem F; Fiel MI; El Jamal SM; Tsankova NM; Houldsworth J; Mussa Z; Veremis B; Sordillo E; Gitman MR; Nowak M; Brody R; Harpaz N; Merad M; Gnjatic S; Liu WC; Schotsaert M; Miorin L; Aydillo Gomez TA; Ramos-Lopez I; Garcia-Sastre A; Donnelly R; Seigler P; Keys C; Cameron J; Moultrie I; Washington KL; Treatman J; Sebra R; Jhang J; Firpo A; Lednicky J; Paniz-Mondolfi A; Cordon-Cardo C; Fowkes ME
    Mod Pathol; 2021 Aug; 34(8):1456-1467. PubMed ID: 33795830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lectin Pathway Mediates Complement Activation by SARS-CoV-2 Proteins.
    Ali YM; Ferrari M; Lynch NJ; Yaseen S; Dudler T; Gragerov S; Demopulos G; Heeney JL; Schwaeble WJ
    Front Immunol; 2021; 12():714511. PubMed ID: 34290717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial injury and thrombotic microangiopathy in COVID-19: Treatment with the lectin-pathway inhibitor narsoplimab.
    Rambaldi A; Gritti G; Micò MC; Frigeni M; Borleri G; Salvi A; Landi F; Pavoni C; Sonzogni A; Gianatti A; Binda F; Fagiuoli S; Di Marco F; Lorini L; Remuzzi G; Whitaker S; Demopulos G
    Immunobiology; 2020 Nov; 225(6):152001. PubMed ID: 32943233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced eosinophil-mediated inflammation associated with antibody and complement-dependent pneumonic insults in critical COVID-19.
    Kim DM; Kim Y; Seo JW; Lee J; Park U; Ha NY; Koh J; Park H; Lee JW; Ro HJ; Yun NR; Kim DY; Yoon SH; Na YS; Moon DS; Lim SC; Kim CM; Jeon K; Kang JG; Jang NY; Jeong H; Kim J; Cheon S; Sohn KM; Moon JY; Kym S; Han SR; Lee MS; Kim HJ; Park WY; Choi JY; Shin HW; Kim HY; Cho CH; Jeon YK; Kim YS; Cho NH
    Cell Rep; 2021 Oct; 37(1):109798. PubMed ID: 34587481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 Antibodies Mediate Complement and Cellular Driven Inflammation.
    Jarlhelt I; Nielsen SK; Jahn CXH; Hansen CB; Pérez-Alós L; Rosbjerg A; Bayarri-Olmos R; Skjoedt MO; Garred P
    Front Immunol; 2021; 12():767981. PubMed ID: 34804055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 Severity Is Associated with Differential Antibody Fc-Mediated Innate Immune Functions.
    Adeniji OS; Giron LB; Purwar M; Zilberstein NF; Kulkarni AJ; Shaikh MW; Balk RA; Moy JN; Forsyth CB; Liu Q; Dweep H; Kossenkov A; Weiner DB; Keshavarzian A; Landay A; Abdel-Mohsen M
    mBio; 2021 Apr; 12(2):. PubMed ID: 33879594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular Disease and Thrombosis in SARS-CoV-2-Infected Rhesus Macaques.
    Aid M; Busman-Sahay K; Vidal SJ; Maliga Z; Bondoc S; Starke C; Terry M; Jacobson CA; Wrijil L; Ducat S; Brook OR; Miller AD; Porto M; Pellegrini KL; Pino M; Hoang TN; Chandrashekar A; Patel S; Stephenson K; Bosinger SE; Andersen H; Lewis MG; Hecht JL; Sorger PK; Martinot AJ; Estes JD; Barouch DH
    Cell; 2020 Nov; 183(5):1354-1366.e13. PubMed ID: 33065030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe COVID-19 is associated with hyperactivation of the alternative complement pathway.
    Boussier J; Yatim N; Marchal A; Hadjadj J; Charbit B; El Sissy C; Carlier N; Pène F; Mouthon L; Tharaux PL; Bergeron A; Smadja DM; Rieux-Laucat F; Duffy D; Kernéis S; Frémeaux-Bacchi V; Terrier B
    J Allergy Clin Immunol; 2022 Feb; 149(2):550-556.e2. PubMed ID: 34800432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defining the Innate Immune Responses for SARS-CoV-2-Human Macrophage Interactions.
    Abdelmoaty MM; Yeapuri P; Machhi J; Olson KE; Shahjin F; Kumar V; Zhou Y; Liang J; Pandey K; Acharya A; Byrareddy SN; Mosley RL; Gendelman HE
    Front Immunol; 2021; 12():741502. PubMed ID: 34671355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thromboinflammation Supports Complement Activation in Cancer Patients With COVID-19.
    Peerschke EI; Valentino A; So RJ; Shulman S; Ravinder
    Front Immunol; 2021; 12():716361. PubMed ID: 34491250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Activation of Complement and Its Role in the Pathogenesis of Thromboembolism.
    Boyce S; Eren E; Lwaleed BA; Kazmi RS
    Semin Thromb Hemost; 2015 Sep; 41(6):665-72. PubMed ID: 26305235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science.
    Evans PC; Rainger GE; Mason JC; Guzik TJ; Osto E; Stamataki Z; Neil D; Hoefer IE; Fragiadaki M; Waltenberger J; Weber C; Bochaton-Piallat ML; Bäck M
    Cardiovasc Res; 2020 Dec; 116(14):2177-2184. PubMed ID: 32750108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation.
    Gu SX; Tyagi T; Jain K; Gu VW; Lee SH; Hwa JM; Kwan JM; Krause DS; Lee AI; Halene S; Martin KA; Chun HJ; Hwa J
    Nat Rev Cardiol; 2021 Mar; 18(3):194-209. PubMed ID: 33214651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement and coagulation: key triggers of COVID-19-induced multiorgan pathology.
    Ghebrehiwet B; Peerschke EI
    J Clin Invest; 2020 Nov; 130(11):5674-5676. PubMed ID: 32925166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement Activation in the Disease Course of Coronavirus Disease 2019 and Its Effects on Clinical Outcomes.
    de Nooijer AH; Grondman I; Janssen NAF; Netea MG; Willems L; van de Veerdonk FL; Giamarellos-Bourboulis EJ; Toonen EJM; Joosten LAB;
    J Infect Dis; 2021 Feb; 223(2):214-224. PubMed ID: 33038254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.